 |
PDBsum entry 1hqx
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
R308k arginase variant
|
|
Structure:
|
 |
Arginase. Chain: a, b, c. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.263
|
R-free:
|
0.296
|
|
|
Authors:
|
 |
L.T.Lavulo,T.M.Sossong Jr.,M.R.Brigham-Burke,M.L.Doyle,J.D.Cox, D.W.Christianson,D.E.Ash
|
Key ref:
|
 |
L.T.Lavulo
et al.
(2001).
Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid.
J Biol Chem,
276,
14242-14248.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Dec-00
|
Release date:
|
06-Jun-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07824
(ARGI1_RAT) -
Arginase-1 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
323 a.a.
314 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
276:14242-14248
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid.
|
|
L.T.Lavulo,
T.M.Sossong,
M.R.Brigham-Burke,
M.L.Doyle,
J.D.Cox,
D.W.Christianson,
D.E.Ash.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the trimeric, manganese metalloenzyme, rat liver arginase, has
been previously determined at 2.1-A resolution (Kanyo, Z. F., Scolnick, L. R.,
Ash, D. E., and Christianson, D. W., (1996) Nature 383, 554-557). A key feature
of this structure is a novel S-shaped oligomerization motif at the carboxyl
terminus of the protein that mediates approximately 54% of the intermonomer
contacts. Arg-308, located within this oligomerization motif, nucleates a series
of intramonomer and intermonomer salt links. In contrast to the trimeric
wild-type enzyme, the R308A, R308E, and R308K variants of arginase exist as
monomeric species, as determined by gel filtration and analytical
ultracentrifugation, indicating that mutation of Arg-308 shifts the equilibrium
for trimer dissociation by at least a factor of 10(5). These monomeric arginase
variants are catalytically active, with k(cat)/K(m) values that are 13-17% of
the value for wild-type enzyme. The arginase variants are characterized by
decreased temperature stability relative to the wild-type enzyme. Differential
scanning calorimetry shows that the midpoint temperature for unfolding of the
Arg-308 variants is in the range of 63.6-65.5 degrees C, while the corresponding
value for the wild-type enzyme is 70 degrees C. The three-dimensional structure
of the R308K variant has been determined at 3-A resolution. At the high protein
concentrations utilized in the crystallizations, this variant exists as a
trimer, but weakened salt link interactions are observed for Lys-308.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The crystal structure of rat liver arginase
showing the trimeric quarternary structure, S-shaped tail in
white at the subunit interface, and two manganese ions (spheres)
at the active site of each subunit. Arg-308 is represented in
the white ball and stick form.
|
 |
Figure 4.
Fig. 4. Differential scanning calorimetry data for the
unfolding of wild-type arginase (solid line), R308A (dashed and
dotted line), R308E (dotted line), and R308K (dashed line) shown
as excess molar heat capacity versus temperature. All scans are
normalized per mole of arginase subunit. Conditions were as
follows: 20 mM NaPO[4], 150 mM NaCl, 0.1 mM MnCl[2], pH 7.4, and
0.4 mg/ml arginase.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
14242-14248)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Srivastava,
and
A.K.Sau
(2010).
Biochemical studies on Helicobacter pylori arginase: insight into the difference in activity compared to other arginases.
|
| |
IUBMB Life,
62,
906-915.
|
 |
|
|
|
|
 |
E.W.Iyamu
(2010).
The redox state of the glutathione/glutathione disulfide couple mediates intracellular arginase activation in HCT-116 colon cancer cells.
|
| |
Dig Dis Sci,
55,
2520-2528.
|
 |
|
|
|
|
 |
G.A.Wells,
I.B.Müller,
C.Wrenger,
and
A.I.Louw
(2009).
The activity of Plasmodium falciparum arginase is mediated by a novel inter-monomer salt-bridge between Glu295-Arg404.
|
| |
FEBS J,
276,
3517-3530.
|
 |
|
|
|
|
 |
J.M.Fitzpatrick,
J.M.Fuentes,
I.W.Chalmers,
T.A.Wynn,
M.Modolell,
K.F.Hoffmann,
and
M.Hesse
(2009).
Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity.
|
| |
Int J Parasitol,
39,
267-279.
|
 |
|
|
|
|
 |
A.Hrabák,
T.Bajor,
and
G.Mészáros
(2008).
The inhibitory effect of various indolyl amino acid derivatives on arginase activity in macrophages.
|
| |
Amino Acids,
34,
293-300.
|
 |
|
|
|
|
 |
D.P.Dowling,
L.Di Costanzo,
H.A.Gennadios,
and
D.W.Christianson
(2008).
Evolution of the arginase fold and functional diversity.
|
| |
Cell Mol Life Sci,
65,
2039-2055.
|
 |
|
|
|
|
 |
E.W.Iyamu,
C.Ekekezie,
and
G.M.Woods
(2007).
In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes.
|
| |
Br J Haematol,
139,
337-343.
|
 |
|
|
|
|
 |
I.B.Müller,
R.D.Walter,
and
C.Wrenger
(2005).
Structural metal dependency of the arginase from the human malaria parasite Plasmodium falciparum.
|
| |
Biol Chem,
386,
117-126.
|
 |
|
|
|
|
 |
S.A.Mohamed,
A.S.Fahmy,
T.M.Mohamed,
and
S.M.Hamdy
(2005).
Urea cycle of Fasciola gigantica: purification and characterization of arginase.
|
| |
Comp Biochem Physiol B Biochem Mol Biol,
142,
308-316.
|
 |
|
|
|
|
 |
R.K.Iyer,
P.K.Yoo,
R.M.Kern,
N.Rozengurt,
R.Tsoa,
W.E.O'Brien,
H.Yu,
W.W.Grody,
and
S.D.Cederbaum
(2002).
Mouse model for human arginase deficiency.
|
| |
Mol Cell Biol,
22,
4491-4498.
|
 |
|
|
|
|
 |
X.Jiang,
J.N.Buxbaum,
and
J.W.Kelly
(2001).
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
|
| |
Proc Natl Acad Sci U S A,
98,
14943-14948.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |